Find Grants for Native American & Tribal Governments

Find Out If You Qualify for Verified Grants! Discover your eligibility and access 1,903 verified grants for nonprofits, small businesses, startups, and individuals from trusted foundations and government sources.

Total Dollar Available
$ 100 Trillion

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

Deadline: October 20, 2027


Opportunity Number: PAR-25-225

Agency: National Institutes of Health

Open Date: November 4, 2024

Close Date: October 20, 2027

Status: Posted

CFDA Numbers: 93.853

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)

Deadline: October 16, 2026


Opportunity Number: PAR-25-077

Agency: National Institutes of Health

Open Date: November 1, 2024

Close Date: October 16, 2026

Status: Posted

CFDA Numbers: 93.853, 93.855

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-143

Agency: National Institutes of Health

Open Date: October 31, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.279, 93.242, 93.273, 93.989, 93.307, 93.172, 93.866, 93.399, 93.846, 93.361, 93.173, 93.121, 93.113, 93.855, 93.865, 93.213, 93.853, 93.310

Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)

Deadline: January 7, 2028


Opportunity Number: PAR-25-207

Agency: National Institutes of Health

Open Date: October 31, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.242

Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)

Deadline: June 2, 2027


Opportunity Number: PAR-25-210

Agency: National Institutes of Health

Open Date: October 31, 2024

Close Date: June 2, 2027

Status: Posted

CFDA Numbers: 93.866, 93.313, 93.393, 93.213, 93.121

Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)

Deadline: June 2, 2027


Opportunity Number: PAR-25-211

Agency: National Institutes of Health

Open Date: October 31, 2024

Close Date: June 2, 2027

Status: Posted

CFDA Numbers: 93.393, 93.121, 93.213, 93.313, 93.866

Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)

Deadline: January 7, 2028


Opportunity Number: PAR-25-206

Agency: National Institutes of Health

Open Date: October 31, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.242

Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)

Deadline: January 27, 2027


Opportunity Number: PAR-24-268

Agency: National Institutes of Health

Open Date: October 30, 2024

Close Date: January 27, 2027

Status: Posted

CFDA Numbers: 93.121, 93.242, 93.866, 93.273, 93.859, 93.853, 93.213, 93.867, 93.279, 93.310, 93.846

Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-233

Agency: National Institutes of Health

Open Date: October 30, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.399, 93.242, 93.121, 93.279, 93.310, 93.113, 93.853, 93.172, 93.989, 93.273, 93.865, 93.866

Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)

Deadline: July 14, 2026


Opportunity Number: PAR-24-313

Agency: National Institutes of Health

Open Date: October 30, 2024

Close Date: July 14, 2026

Status: Posted

CFDA Numbers: 93.213

Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-185

Agency: National Institutes of Health

Open Date: October 30, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.865, 93.121, 93.351

Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)

Deadline: July 14, 2026


Opportunity Number: PAR-24-312

Agency: National Institutes of Health

Open Date: October 29, 2024

Close Date: July 14, 2026

Status: Posted

CFDA Numbers: 93.213

Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)

Deadline: April 15, 2027


Opportunity Number: PAR-25-131

Agency: National Institutes of Health

Open Date: October 29, 2024

Close Date: April 15, 2027

Status: Posted

CFDA Numbers: 93.879

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-144

Agency: National Institutes of Health

Open Date: October 29, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.279, 93.242, 93.273, 93.866, 93.847, 93.307, 93.172, 93.846, 93.399, 93.853, 93.837, 93.361, 93.867, 93.855, 93.213, 93.121, 93.865, 93.113, 93.839, 93.840, 93.233, 93.838, 93.310

High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)

Deadline: June 1, 2027


Opportunity Number: PAR-24-264

Agency: National Institutes of Health

Open Date: October 29, 2024

Close Date: June 1, 2027

Status: Posted

CFDA Numbers: 93.351, 93.859, 93.286

Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)

Deadline: June 1, 2027


Opportunity Number: PAR-24-326

Agency: National Institutes of Health

Open Date: October 29, 2024

Close Date: June 1, 2027

Status: Posted

CFDA Numbers: 93.351, 93.859

Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)

Deadline: June 1, 2027


Opportunity Number: PAR-24-265

Agency: National Institutes of Health

Open Date: October 29, 2024

Close Date: June 1, 2027

Status: Posted

CFDA Numbers: 93.351, 93.286, 93.866, 93.242, 93.867, 93.859

Translational Neural Devices (R61/R33 - Clinical Trial Optional)

Deadline: January 28, 2027


Opportunity Number: PAR-25-053

Agency: National Institutes of Health

Open Date: October 29, 2024

Close Date: January 28, 2027

Status: Posted

CFDA Numbers: 93.853

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-024

Agency: National Institutes of Health

Open Date: October 28, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.853, 93.866

Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)

Deadline: November 5, 2027


Opportunity Number: PAR-25-149

Agency: National Institutes of Health

Open Date: October 28, 2024

Close Date: November 5, 2027

Status: Posted

CFDA Numbers: 93.853

Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)

Deadline: November 16, 2027


Opportunity Number: PAR-25-122

Agency: National Institutes of Health

Open Date: October 28, 2024

Close Date: November 16, 2027

Status: Posted

CFDA Numbers: 93.121, 93.853, 93.173, 93.350, 93.855, 93.242

BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)

Deadline: June 15, 2027


Opportunity Number: RFA-MH-26-140

Agency: National Institutes of Health

Open Date: October 23, 2024

Close Date: June 15, 2027

Status: Posted

CFDA Numbers: 93.286, 93.173, 93.867, 93.213, 93.273, 93.853, 93.866, 93.242, 93.865

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Deadline: January 6, 2028


Opportunity Number: PAR-25-057

Agency: National Institutes of Health

Open Date: October 23, 2024

Close Date: January 6, 2028

Status: Posted

CFDA Numbers: 93.121

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

Deadline: October 20, 2027


Opportunity Number: PAR-25-060

Agency: National Institutes of Health

Open Date: October 22, 2024

Close Date: October 20, 2027

Status: Posted

CFDA Numbers: 93.853

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Deadline: October 20, 2027


Opportunity Number: PAR-25-059

Agency: National Institutes of Health

Open Date: October 22, 2024

Close Date: October 20, 2027

Status: Posted

CFDA Numbers: 93.853